Gao E, Yang C, Li H, Duan Y, Zhou Y
Cardiovascular Division, Henan Provincial People's Hospital, Zhengzhou, China.
Chin Med J (Engl). 1997 Sep;110(9):723-5.
To compare the effects of metoprolol and propafenone in patients with ventricular arrhythmia (VA) of positive ventricular late potential (VLP) and to discuss the effect of medicine on high risk VA.
30 A total of 128 patients (78 males and 50 females) with VA of positive VLP were randomly divided into 3 groups. Groups A and B were given metoprolol and propafenone respectively, group C was given vitamin C as placebo. Twenty-four hours dynamic electrocardiogram and VLP were examined before treatment and 4 weeks after treatment.
Propafenone could effectively control VA but could not reverse positive VLP to negative meanwhile it had proarrhythmia effect (2/40), metoprolol could effectively control VA (38/46) and reverse positive VLP to negative (39/46) with no obvious side effects. The dosage from 50 to 100 mg/day made no difference. VA and VLP had no significant changes in group C.
Metoprolol is superior to other medicine for VA of positive VLP when the patients have no contraindication of preceptor blocking agents.
比较美托洛尔与普罗帕酮对心室晚电位(VLP)阳性的室性心律失常(VA)患者的疗效,并探讨药物对高危VA的作用。
将128例VLP阳性的VA患者(男78例,女50例)随机分为3组。A组和B组分别给予美托洛尔和普罗帕酮,C组给予维生素C作为安慰剂。治疗前及治疗4周后进行24小时动态心电图及VLP检查。
普罗帕酮能有效控制VA,但不能使阳性VLP转为阴性,同时有促心律失常作用(2/40);美托洛尔能有效控制VA(38/46),并使阳性VLP转为阴性(39/46),且无明显副作用。50~100mg/天的剂量无差异。C组VA和VLP无明显变化。
当患者无β受体阻滞剂禁忌证时,美托洛尔治疗VLP阳性的VA优于其他药物。